Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xihui Liu

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Breast Cancer Research : BCR|December 28, 2019
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, et al.
Nature Cancer|October 14, 2022
Author Correction: Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistanceSu Deng, Choushi Wang, Yunguan Wang, et al.
Cancers|February 10, 2024
Novel LIPA-Targeted Therapy for Treating Ovarian CancerAlexia B Collier, Suryavathi Viswanadhapalli, Rahul Gopalam, et al.
Nature Cancer|September 6, 2022
Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistanceSu Deng, Choushi Wang, Yunguan Wang, et al.
Cancer Research|July 30, 2017
Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer IrradiationYi Yin, Rui Li, Kangling Xu, et al.
Cancer Cell|July 21, 2023
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Yunguan Wang, Su Deng, et al.
Nature Cancer|June 2, 2022
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.
Nature Cancer|May 20, 2024
Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.
Oncogene|February 6, 2026
Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancerSuryavathi Viswanadhapalli, Tae-Kyung Lee, Scott Elmore, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Breast Cancer Research : BCR|December 28, 2019
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, et al.
Nature Cancer|October 14, 2022
Author Correction: Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistanceSu Deng, Choushi Wang, Yunguan Wang, et al.
Cancers|February 10, 2024
Novel LIPA-Targeted Therapy for Treating Ovarian CancerAlexia B Collier, Suryavathi Viswanadhapalli, Rahul Gopalam, et al.
Nature Cancer|September 6, 2022
Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistanceSu Deng, Choushi Wang, Yunguan Wang, et al.
Cancer Research|July 30, 2017
Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer IrradiationYi Yin, Rui Li, Kangling Xu, et al.
Cancer Cell|July 21, 2023
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Yunguan Wang, Su Deng, et al.
Nature Cancer|June 2, 2022
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.
Nature Cancer|May 20, 2024
Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stressXihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, et al.
Oncogene|February 6, 2026
Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancerSuryavathi Viswanadhapalli, Tae-Kyung Lee, Scott Elmore, et al.
Pageof 5